NEW YORK ( TheStreet) -- CHANGE IN RATINGS AES ( AES) upgraded to buy at TheStreet Ratings. AIG ( AIG) upgraded to hold at TheStreet Ratings. Clear Channel Outdoor ( CCO) downgraded at Wedbush to Neutral, Wedbush said. Valuation call, based on a $12.50 price target. Cooper Tire ( CTB) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on an $18.50 price target. Jive Software ( JIVE) rated new Neutral at Baird. Valuation call, based on a $21 price target. LinkedIn ( LNKD) rated new Market Perform at BMO. $95 price target. Unique social offering with multiple levers to pull. Newmont Mining ( NEM) downgraded at TD Securities To Hold from Buy, TD Securities said. $73 price target. Risk in Conga and Cerro Quilish. Public Service ( PEG) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $30 price target. Company will be hurt by lower power prices. Penn National ( PENN) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. Valuation call, based on a $44 price target. Procter & Gamble ( PG) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $75 price target. Company is looking to deliver $10 billion in cost savings by 2016. Salix Pharmaceuticals ( SLXP) upgraded at Auriga to Buy from Hold, Auriga said. $54 price target. 2012 guidance appears conservative. Southwestern Energy ( SWN) downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Test well did not do well in Brown Dense. Thompson Creek ( TC) downgraded at Deutsche from Hold to Sell, Deutsche Bank said. Company is spending more on capex. $7.50 price target. Tetra Tech ( TTEK) upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $30 price target. Company can sustain 15% annual earnings growth over the next three years. USG ( USG) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Channel checks suggest a successful 35% price increase. $18.50 price target.
STOCK COMMENTS / EPS CHANGESAmetek ( AME) target raised at Oppenheimer to $57, Oppenheimer said. Positive meetings with management. Outperform rating. Dendreon ( DNDN) estimates, target reduced at Credit Suisse. Shares of DNDN now seen reaching $13, according to Credit Suisse. Estimates also cut, as the company is seeing lumpy sales. Neutral rating. Darden Restaurants ( BMO) numbers raised at BMO. Shares of BMO now seen reaching $57, according to BMO Capital. Estimates also increased, as the company is cutting costs. Market Perform rating.
Forest Oil ( FST) numbers cut at Credit Suisse through 2013, Credit Suisse said. Eagle Ford is yielding less. Outperform rating and new $17 price target. HSBC ( HBC) estimates, target raised at UBS. Shares of HBC now seen reaching $45.67, according to UBS. Estimates also increased related to 14% dividend hike. Neutral rating. Human Genome ( HGSI) numbers lowered at ThinkEquity. Shares of HGSI now seen reaching $15, according to ThinkEquity. Estimates also cut, given lower expected Benlysta sales. Buy rating. Lowe's ( LOW) numbers raised at UBS. Shares of LOW now seen reaching $32, according to UBS. Estimates also increased on signs of progress in its transformation. Lowe's estimates, target raised at Goldman. Shares of LOW now seen reaching $32, according to Goldman Sachs. Estimates also increased, as the company is buying back more stock. Prosperity Bancshares ( PB) numbers boosted at Morgan Stanley. Shares of PB now seen reaching $48, according to Morgan Stanley. Estimates also upped, as the American State acquisition should add to earnings. Equal-weight rating. Priceline.com ( PCLN) estimates, target raised at UBS. Shares of PCLN now seen reaching $680, according to UBS. Estimates also increased on strong guidance. Neutral rating. Priceline.com numbers increased at Goldman. PCLN estimates were raised through 2013, Goldman Sachs said. Company is gaining market share. Buy rating and new $700 price target. Priceline.com numbers raised at Citigroup. Shares of PCLN now seen reaching $850, according to Citigroup. Estimates also increased on very clean beat in December quarter. Buy rating. Transocean ( RIG) estimates raised at UBS through 2013, UBS said. Underlying industry fundamentals continue to improve. Buy rating and $62 price target. Transocean estimates upped at BMO through 2013, BMO Capital said. Company is seeing higher sales. Outperform rating and $65 price target. Salix Pharmaceuticals ( SLXP) numbers cut at Credit Suisse. Shares of SLXP now seen reaching $53, according to Credit Suisse. Estimates also reduced, Company is seeing higher operating costs. Outperform rating. Southwestern Energy ( SWN) numbers trimmed at UBS. Shares of SWN now seen reaching $40, according to UBS. Estimates also lowered on lower than expected gas realizations and higher costs. Buy rating. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.
Twitter and become a fan on Facebook.